Cite

    Haiyan Zhou et al.. “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.” Journal of cachexia, sarcopenia and muscle, vol. 11, no. 3, 2020, pp. 768–782. http://access.bl.uk/ark:/81055/vdc_100102729873.0x000009